1. Home
  2. IRON vs ARCB Comparison

IRON vs ARCB Comparison

Compare IRON & ARCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$68.20

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo ArcBest Corporation

ARCB

ArcBest Corporation

HOLD

Current Price

$129.30

Market Cap

2.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRON
ARCB
Founded
2017
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trucking Freight/Courier Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.7B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
IRON
ARCB
Price
$68.20
$129.30
Analyst Decision
Strong Buy
Buy
Analyst Count
11
12
Target Price
$103.18
$122.75
AVG Volume (30 Days)
426.0K
315.9K
Earning Date
05-07-2026
04-28-2026
Dividend Yield
N/A
0.38%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,657,864,000.00
Revenue This Year
N/A
$7.00
Revenue Next Year
$283.52
$5.80
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.56
52 Week Low
$40.00
$59.43
52 Week High
$99.50
$135.10

Technical Indicators

Market Signals
Indicator
IRON
ARCB
Relative Strength Index (RSI) 51.91 64.13
Support Level $58.13 $115.28
Resistance Level $71.53 $135.10
Average True Range (ATR) 3.23 4.65
MACD -0.17 0.22
Stochastic Oscillator 46.09 94.52

Price Performance

Historical Comparison
IRON
ARCB

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About ARCB ArcBest Corporation

ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.

Share on Social Networks: